Does a Free Office Visit Affect Primary Care–Seeking Behavior? A Study of New Exchange Health Plan Enrollees in Mississippi
Bettina M. Beech, DrPH, MPH, Tristan Cordier, MPH, Laura E. Happe, PharmD, MPH, Laura Trunk, MD, Gilbert S. Haugh, MS, Richard Kwong, MPH, Vipin Gopal, PhD, Roy A. Beveridge, MD
In recent years, several health plans in the Health Insurance Marketplace exchange were offering free doctors’ visits to their members, with the hope of identifying illnesses before they become more difficult or more expensive to treat.
Patients’ Choice for Site of Care Motivated by More Than Cost Alone
Comparing Healthcare Costs Associated with Oral and Subcutaneous Methotrexate or Biologic Therapy for Rheumatoid Arthritis in the United States
Joseph Lee, PhD, Ryan Pelkey, MS, Julieanna Gubitosa, BS, Michael F. Henrick, MBA, Michael L. Ganz, MS, PhD
Rheumatoid arthritis (RA) is the most common autoimmune inflammatory arthritis in adults, with a prevalence of approximately 0.6% in the United States. RA has a significant negative impact on health-related quality of life and imposes a substantial economic burden on the US healthcare system.
Identifying the Most Clinically and Economically Effective Therapies for Rheumatoid Arthritis Remains a Challenge for Providers and Payers
Sociodemographic Determinants of Out-of-Pocket Expenditures for Patients Using Prescription Drugs for Rheumatoid Arthritis
Rheumatoid arthritis (RA) is a chronic inflammatory disease that is typically accompanied by swelling, tenderness of the joints, and destruction of the synovial joints. The progression of RA can cause disability and can have serious physical, mental, and economic consequences for patients.
Understanding Patients’ Demographics Is Key to Improving Clinical and Economic Healthcare Outcomes
Biologic Disease-Modifying Antirheumatic Drugs in a National, Privately Insured Population: Utilization, Expenditures, and Price Trends
Rheumatoid arthritis (RA) is a chronic systemic inflammatory disease of unknown cause that primarily affects the peripheral joints in a symmetric pattern. RA’s effect on other areas of the body, including the skin, heart, lungs, and eyes, can be substantial.
Rheumatoid Arthritis, Biologic Drugs, and Associated Cost
Leveraging Real-World Evidence in Disease-Management Decision-Making with a Total Cost of Care Estimator
Thanh-Nghia Nguyen, DrPH, MPH, MBA, Jeffrey Trocio, MPH, Stacey Kowal, MS, Cheryl P. Ferrufino, Julie Munakata, MS, Dell South, PharmD
The healthcare system in the United States is evolving as a result of the increasing availability of real-world data and the influence of value-based policy and quality initiatives.
Hypothesis Generation: An Essential Component of Informed Healthcare Management
Use of the Prostate Core Mitomic Test in Repeated Biopsy Decision-Making: Real-World Assessment of Clinical Utility in a Multicenter Patient Population
Prostate cancer is the second most common invasive cancer diagnosed among men worldwide, and the most common cancer diagnosed in developed regions of the world, with an estimated age-standardized rate of 63 cases per 100,000 person-years.
Molecular Tests May Aid Clinical Decision-Making and Reduce Healthcare Costs
Jun Tang, PhD, James Bailey, MD, MPH, Cyril Chang, PhD, Richard Faris, PhD, Song Hee Hong, PhD, Michael Levin, MD, Junling Wang, PhD
Multiple sclerosis (MS) is a chronic, debilitating disease that attacks the central nervous system. It is estimated that approximately 400,000 people are living with MS in the United States, and approximately 10,400 patients are newly diagnosed with the disease annually.
What Makes Specialty Pharmacy Care So Special?
Hospital and Health Plan Partnerships: The Affordable Care Act’s Impact on Promoting Health and Wellness
Michelle Vu, PharmD candidate, Annesha White, PharmD, PhD, Virginia P. Kelley, MBA, Jennifer Kuca Hopper, MS, Cathy Liu, PharmD candidate
The growing number of partnerships between hospitals, outpatient care providers, and academic medical centers has been attributed, at least in part, to the healthcare reform initiated by the Affordable Care Act (ACA), which rewards hospitals for improving patient health outcomes and reducing healthcare costs.
Measurable Clarity in Healthcare Is Needed So Those Who Use the System Could Achieve a State of Well-Being
S. Pinar Bilir, MS, Qiufei Ma, PhD, Zhongyun Zhao, PhD, Elizabeth Wehler, MPH, Julie Munakata, MS, Beth Barber, PhD
Malignant melanoma is the sixth most often diagnosed cancer in the US. With new treatment options, here is an examination of costs associated with treating adverse events with various therapies.
Reducing Adverse Events and Healthcare Resource Waste by Careful Selection of the Best Drug Therapy
Page 1 of 11
Results 1 - 10 of 101
Results 1 - 10 of 101